TF and renal cell carcinoma: If such an “omnigenic” characterization is reflective of the genetic architecture of RCC, then identifying the potential genes and proteins trans-associated with TF binding disruptions at RCC-associated GWAS loci can help prioritize putative disease-relevant molecular targets.